Is ADMA Biologics (ADMA) Outperforming Other Medical Stocks This Year?

Zacks08-29

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Adma Biologics (ADMA) one of those stocks right now? Let's take a closer look at ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2463660342?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/eeFsK50..hTdRBoBNDEyoA--~B/aD03MTE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d2f7ed3d1940141716bfd200f5c94c6b","is_english":true,"pubTime":"2024-08-29 21:40","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2463660342","market":"us","top_or_hot":-1,"title":"Is ADMA Biologics (ADMA) Outperforming Other Medical Stocks This Year?","media":"Zacks","content":"<div>\n<p>Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Adma Biologics (ADMA) one of those stocks right now? Let's take a closer look at ...</p>\n\n<a href=\"https://finance.yahoo.com/news/adma-biologics-adma-outperforming-other-134012965.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is ADMA Biologics (ADMA) Outperforming Other Medical Stocks This Year?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs ADMA Biologics (ADMA) Outperforming Other Medical Stocks This Year?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-29 21:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/adma-biologics-adma-outperforming-other-134012965.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Adma Biologics (ADMA) one of those stocks right now? Let's take a closer look at ...</p>\n\n<a href=\"https://finance.yahoo.com/news/adma-biologics-adma-outperforming-other-134012965.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CDNA","symbol_name":"CareDx","start_time":0,"source_url":"https://finance.yahoo.com/news/adma-biologics-adma-outperforming-other-134012965.html","article_id":"2463660342","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/eeFsK50..hTdRBoBNDEyoA--~B/aD03MTE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d2f7ed3d1940141716bfd200f5c94c6b"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2463660342","pubTimestamp":1724938812,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Adma Biologics  one of those stocks right now?Let's take a closer look at the stock's year-to-date performance to find out.Adma Biologics is a member of our Medical group, which includes 1017 different companies and currently sits at #6 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Adma Biologics is currently sporting a Zacks Rank of #2 .For CareDx, the consensus EPS estimate for the current year has increased 43.4% over the past three months. The stock currently has a Zacks Rank #2 .","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"CDNA":"CareDx","ADMA":"ADMA Biologics Inc"},"translate_title":"ADMA Biologics(ADMA)今年的表现是否优于其他医疗股？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ADMA":1,"CDNA":0.9},"content_text":"Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Adma Biologics (ADMA) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.\nAdma Biologics is a member of our Medical group, which includes 1017 different companies and currently sits at #6 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.\nThe Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Adma Biologics is currently sporting a Zacks Rank of #2 (Buy).\nThe Zacks Consensus Estimate for ADMA's full-year earnings has moved 40% higher within the past quarter. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.\nBased on the most recent data, ADMA has returned 281.4% so far this year. In comparison, Medical companies have returned an average of 11.5%. This means that Adma Biologics is performing better than its sector in terms of year-to-date returns.\nOne other Medical stock that has outperformed the sector so far this year is CareDx (CDNA). The stock is up 152% year-to-date.\nFor CareDx, the consensus EPS estimate for the current year has increased 43.4% over the past three months. The stock currently has a Zacks Rank #2 (Buy).\nLooking more specifically, Adma Biologics belongs to the Medical - Biomedical and Genetics industry, a group that includes 497 individual stocks and currently sits at #82 in the Zacks Industry Rank. On average, stocks in this group have gained 1.9% this year, meaning that ADMA is performing better in terms of year-to-date returns.\nOn the other hand, CareDx belongs to the Medical Services industry. This 57-stock industry is currently ranked #168. The industry has moved +7.3% year to date.\nGoing forward, investors interested in Medical stocks should continue to pay close attention to Adma Biologics and CareDx as they could maintain their solid performance.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nADMA Biologics Inc (ADMA) : Free Stock Analysis Report\nCareDx, Inc. (CDNA) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2463660342"}